Horm Metab Res 2010; 42(12): 831-836
DOI: 10.1055/s-0030-1263124
Original Basic

© Georg Thieme Verlag KG Stuttgart · New York

The Anti-adipogenic Effect of Macrophage-conditioned Medium Requires the IKKβ/NF-κB Pathway

M. N. Yarmo1 , 2 , A. Gagnon1 , 2 , A. Sorisky1 , 2
  • 1Chronic Disease Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
  • 2Departments of Medicine and of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada
Further Information

Publication History

received 28.05.2010

accepted 22.07.2010

Publication Date:
27 August 2010 (online)

Abstract

Macrophage-secreted factors inhibit adipogenesis, but the underlying mechanism is not well understood. Our objective was to determine if anti-adipogenic signaling pathways in human preadipocytes are activated by macrophage-conditioned medium (MacCM). Human abdominal subcutaneous stromal preadipocytes were treated with adipogenic inducers in either standard medium or medium conditioned by human THP-1 macrophages. THP-1-MacCM increased inhibitor of κB kinase β (IKKβ) phosphorylation, inhibitor of NF-κB α (IκBα) degradation, and NF-κB activity in human preadipocytes in a time-dependent manner. Concomitant treatment of human abdominal subcutaneous preadipocytes with sc-514, a selective inhibitor of IKKβ, prevented the inhibitory effect of THP-1-MacCM on lipid accumulation and expression of adipogenic markers. Our data indicate that activation of the preadipocyte IKKβ/NF-κB pathway is required for the anti-adipogenic effect of THP-1-MacCM on human adipogenesis.

References

  • 1 Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AWJ. Obesity is associated with macrophage accumulation in adipose tissue.  J Clin Invest. 2003;  112 1796-1808
  • 2 Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.  J Clin Invest. 2003;  112 1821-1830
  • 3 de Luca C, Olefsky JM. Inflammation and insulin resistance.  FEBS Lett. 2008;  582 97-105
  • 4 Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao HJ, Hotamisligil GS. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice.  J Clin Invest. 2008;  118 2640-2650
  • 5 Hotamisligil GS. Inflammation and metabolic disorders.  Nature. 2006;  444 860-867
  • 6 Constant VA, Gagnon A, Landry A, Sorisky A. Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes.  Diabetologia. 2006;  49 1402-1411
  • 7 Constant VA, Gagnon A, Yarmo M, Sorisky A. The antiadipogenic effect of macrophage-conditioned medium depends on ERK1/2 activation.  Metabolism. 2008;  57 465-472
  • 8 Yarmo MN, Landry A, Molgat AS, Gagnon A, Sorisky A. Macrophage-conditioned medium inhibits differentiation-induced Rb phosphorylation in 3T3-L1 preadipocytes.  Exp Cell Res. 2009;  315 411-418
  • 9 Lacasa D, Taleb S, Keophiphath M, Miranville A, Clement K. Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes.  Endocrinology. 2007;  148 868-877
  • 10 Stienstra R, Duval C, Keshtkar S, van der Laak J, Kersten S, Müller M. Peroxisome proliferator-activated receptor γ activation promotes infiltration of alternatively activated macrophages into adipose tissue.  J Biol Chem. 2008;  283 22620-22627
  • 11 Heilbronn L, Smith SR, Ravussin E. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type 2 diabetes mellitus.  Int J Obesity. 2004;  28 S12-S21
  • 12 Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E. Look AHEAD Adipose Research Group. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes.  Obesity. 2006;  14 1543-1552
  • 13 Karin M. The IκB kinase – a bridge between inflammation and cancer.  Cell Res. 2008;  18 334-342
  • 14 Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis.  Arterioscler Thromb Vasc Biol. 2007;  27 2276-2283
  • 15 Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.  J Biol Chem. 1997;  272 3406-3410
  • 16 Gagnon A, Landry A, Sorisky A. IKKβ and the anti-adipogenic effect of platelet-derived growth factor in human abdominal subcutaneous preadipocytes.  J Endocrinol. 2009;  201 75-80
  • 17 Molgat AS, Gagnon A, Sorisky A. Preadipocyte apoptosis is prevented by macrophage-conditioned medium in a PDGF-dependent manner.  Am J Physiol Cell Physiol. 2009;  296 C757-C765
  • 18 Gagnon A, Chen C-S, Sorisky A. Activation of protein kinase B and induction of adipogenesis by insulin in 3T3-L1 preadipocytes. Contribution of phosphoinositide-3,4,5-trisphosphate versus phosphoinositide-3,4-bisphosphate.  Diabetes. 1999;  48 691-698
  • 19 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.  Nature. 1970;  227 680-685
  • 20 Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: a treasure trove for drug development.  Nat Rev Drug Discov. 2004;  3 17-26
  • 21 Kishore N, Sommers C, Mathialagan S, Guzova J, Yao M, Hauser S, Huynh K, Bonar S, Mielke C, Albee L, Weier R, Graneto M, Hanau C, Perry T, Tripp CS. A selective IKK-2 inhibitor blocks NF-κB-dependent gene expression in interleukin-1β-stimulated synovial fibroblasts.  J Biol Chem. 2003;  278 32861-32871
  • 22 Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine.  Genes Dev. 2008;  22 1276-1312
  • 23 Hauner H, Rohrig K, Petruschke T. Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function.  Eur J Clin Invest. 1995;  25 90-96
  • 24 Suzawa M, Takada I, Yanagisawa J, Ohtake F, Ogawa S, Yamauchi T, Kadowaki T, Takeuchi Y, Shibuya H, Gotoh Y, Matsumoto K, Kato S. Cytokines suppress adipogenesis and PPAR-γ function through the TAK1/TAB1/NIK cascade.  Nat Cell Biol. 2003;  5 224-230
  • 25 Kosaka C, Masuda J, Shimokado K, Zen K, Yokota T, Sasaguri T, Ogata J. Interferon-γ suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages.  Atherosclerosis. 1992;  97 75-87
  • 26 Auwerx J. The human leukemia cell line, THP-1: a multifunctional model for the study of monocyte-macrophage differentiation.  Experientia. 1991;  47 22-31
  • 27 Bassols J, Ortega FJ, Moreno-Navarrete JM, Peral B, Ricart W, Fernández-Real JM. Study of the proinflammatory role of human differentiated omental adipocytes.  J Cell Biochem. 2009;  107 1107-1117
  • 28 Lu C, Kumar PA, Fan Y, Sperling MA, Menon RK. A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation.  Endocrinology. 2010;  151 189-199
  • 29 Entenmann G, Hauner H. Relationship between replication and differentiation in cultured human adipocyte precursor cells.  Am J Physiol. 1996;  270 C1011-C1016
  • 30 Tang Q-Q, Otto TC, Lane MD. Mitotic clonal expansion: a synchronous process required for adipogenesis.  Proc Natl Acad Sci USA. 2003;  100 44-49
  • 31 Arner E, Westermark PO, Spalding KL, Britton T, Ryden M, Frisen J, Bernard S, Arner P. Adipocyte turnover: relevance to human adipose tissue morphology.  Diabetes. 2010;  59 105-109
  • 32 Skurk T, Kempf K, Kolb H, Hauner H. Herder. Expression and secretion of RANTES (CCL5) in human adipocytes in response to immunological stimuli and hypoxia.  Horm Metab Res. 2009;  183-189

Correspondence

Dr. A. Sorisky

Ottawa Hospital Research

Institute

501 Smyth Road Ottawa

K1 H 8L6 Ontario

Canada

Phone: +1/613/737 8899 #73320

Fax: +1/613/737 8803

Email: asorisky@ohri.ca